Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 149

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 149
---
                 
 the amortization of the remaining debt discount related to the Convertible Bridge Notes. |

| EE. | Reflects                                                                                       
 the expensing of the $45.1 million of acquired Legacy CERo in-process research and development |

Note 5. Net Loss per Share

Net loss per share was calculated
using the historical weighted average shares outstanding, and the issuance of additional shares in connection with the Business Combination
and the related transactions, assuming the shares were outstanding since January 1, 2023. As the Business Combination and the related
transactions are being reflected as if they had occurred at the beginning of the period presented, the calculation of weighted average
shares outstanding for basic and diluted net loss per share assumes that the shares issuable relating to the Business Combination and
related have been outstanding for the entirety of the period presented.

The following has been prepared
to present the net loss per share, at the time of the Business Combination for the year ended December 31, 2023, both prior to and retroactively
adjusted for the Reverse Stock Split:

|                                                         |     | Pre-Reverse 
 Stock Split |             |   |     | Post-Reverse 
 Stock Split  |             |   |
|:--------------------------------------------------------|:----|:------------|------------:|:--|:----|:-------------|------------:|:--|
| Pro forma net loss                                      |     | $           | (54,910,374 | ) |     | $            | (54,910,374 | ) |
| Weighted average shares outstanding – basic and diluted |     |             |  14,706,847 |   |     |              |     147,068 |   |
| Net loss per share – basic and diluted                  |     | $           |       (3.73 | ) |     | $            |     (373.37 | ) |
| Excluded securities                                     |     |             |             |   |     |              |             |   |
| Private Placement Warrants                              |     |             |     442,500 |   |     |              |       4,425 |   |
| Public Warrants                                         |     |             |   8,750,000 |   |     |              |      87,500 |   |
| Investor warrants                                       |     |             |     612,746 |   |     |              |       6,127 |   |
| Legacy CERo warrants                                    |     |             |